Gene · 5337
Papers1,924
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,924
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A case report of right ventricular cardiomyopathy with right ventricular diverticulum and atrial septal defect associated with biallelic PLD1 gene variants. | Eur Heart J Case Rep | 2026 | 42799239 | PubTator, text mining | PubMed |
| Novel compound heterozygous variants in the PLD1 gene causing cardiac valve dysplasia 1 complicated with dilated cardiomyopathy: a case report. | Front Cardiovasc Med | 2026 | 42591229 | PubTator, text mining | PubMed |
| Structural insights into the activation of phospholipase D1 by the small GTPase ARL11. | J Biol Chem | 2026 | 42520942 | PubTator, text mining | PubMed |
| PLD1 and PLD2 promote an immunosuppressive tumor microenvironment via CCL19-dependent macrophage polarization and PD-L1 induction. | Exp Mol Med | 2026 | 42243532 | PubTator, text mining | PubMed |
| Involvement of TRPA1 in Necrosis of Melanoma Cells via Phospholipase D1. | Cells | 2026 | 42121861 | PubTator, text mining | PubMed |
| Phospholipase D1 and phosphatidic acid are required for MVE fusion and exosome secretion. | Biophys J | 2026 | 41947465 | PubTator, text mining | PubMed |
| Quizartinib and omacetaxine mepesuccinate combination therapy in FLT3-ITD AML: a phase II trial. | Nat Commun | 2026 | 41942459 | PubTator, text mining | PubMed |
| Understanding the Molecular Basis of Pathological Retinal Angiogenesis: Roles of Lipids, Non-Coding RNAs, and Cellular Crosstalk. | Invest Ophthalmol Vis Sci | 2026 | 41837574 | PubTator, text mining | PubMed |
| Exploring the PLD1-tau interaction in Frontotemporal Dementia. | bioRxiv | 2026 | 41726972 | PubTator, text mining | PubMed |
| Shielding retinal pigment epithelium cells from high glucose-induced oxidative stress: the protective effect of phospholipase D (PLD) pathway inhibition. | Biochim Biophys Acta Mol Cell Res | 2026 | 41617127 | PubTator, text mining | PubMed |
| Blocking Sphingosine 1-phosphate Metabolism With Fingolimod Prevents the Progression of Vascular Smooth Muscle Cells Calcification in Chronic Kidney Disease. | J Cell Physiol | 2026 | 41560531 | PubTator, text mining | PubMed |
| The significance of immunogenic cell death related prognostic gene markers in colorectal cancer prognosis and antitumor immunity. | Sci Rep | 2026 | 41559128 | PubTator, text mining | PubMed |
| Phosphatidic acid at the crossroads of membrane dynamics: from molecular specificity to synthetic innovation. | Adv Biol Regul | 2026 | 41173720 | PubTator, text mining | PubMed |
| Programmed Death Ligand-1 Expression and Its Determinants in Patients with Lung Cancer: A Tertiary Care Center Experience in India. | Ann Afr Med | 2026 | 40831410 | PubTator, text mining | PubMed |
| Targeted lipidomics meets transcriptomics: how cinobufagin rewires fatty acid, sphingolipid, and glycerophospholipid metabolism to combat hepatoma cell growth. | Front Pharmacol | 2025 | 41737012 | PubTator, text mining | PubMed |
| Genetic etiology and pregnancy outcomes of abnormal fluid accumulation in fetus: A retrospective cohort study. | PLoS One | 2025 | 41401185 | PubTator, text mining | PubMed |
| Phospholipase D2 regulation by transcription factor FOXA1 promotes the drug resistance of vemurafenib in melanoma cells. | Biochem Pharmacol | 2025 | 41110487 | PubTator, text mining | PubMed |
| Exosome-Mediated Delivery of a PLD1 Modulator Overcomes Bioavailability Hurdles to Target Synaptopathy in Neurodegenerative Diseases. | Pharm Res | 2025 | 41087673 | PubTator, text mining | PubMed |
| 401-Gene Signature of Myocardial Dysfunction in Human Heart Failure: A Transcriptomic Analysis. | Cureus | 2025 | 41063917 | PubTator, text mining | PubMed |
| Golgi retention of KIT in gastrointestinal stromal tumour cells is phospholipase D activity-dependent. | Sci Rep | 2025 | 40770227 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5337/papers